Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreeff

Showing results (231-240 of 315) with videos related to

Pageof 32
Sort By:
Bone Marrow Transplantation|May 1, 1994
Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantationM Körbling, J Drach, R E Champlin, et al.
Blood|November 15, 1996
Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and BaxM Lisovsky, Z Estrov, X Zhang, et al.
Leukemia|March 22, 2017
Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivoH Zhou, P Y Mak, H Mu, et al.
Biomedizinische Technik. Biomedical Engineering|December 22, 1998
[Equipment for modification of nuclear medicine lung diagnosis as triggered SPECT--presentation, phantom studies and clinical value]M Andreeff, J Kropp, B Beuthien-Baumann, et al.
Leukemia & Lymphoma|January 1, 1995
Growth-factor stimulation reveals two mechanisms of retinoblastoma gene inactivation in human myelogenous leukemia cellsW Zhang, H J Xu, S M Kornblau, et al.
Human Gene Therapy|June 28, 2001
Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenesS Takahashi, R F Rousseau, P Yotnda, et al.
Cancer Research|September 1, 1983
Flow cytometry in clinical cancer researchB Barlogie, M N Raber, J Schumann, et al.
Leukemia|February 1, 1989
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocolE Berman, Z A Arlin, J Gaynor, et al.
Seminars in Oncology|February 1, 1989
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer CenterE Berman, V Raymond, T Gee, et al.
Journal of Hematotherapy|January 1, 1993
Genetic therapy of human neoplastic diseaseA B Deisseroth, E G Hanania, S Fu, et al.
Pageof 32

Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
Bone Marrow Transplantation|May 1, 1994
Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantationM Körbling, J Drach, R E Champlin, et al.
Blood|November 15, 1996
Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and BaxM Lisovsky, Z Estrov, X Zhang, et al.
Leukemia|March 22, 2017
Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivoH Zhou, P Y Mak, H Mu, et al.
Biomedizinische Technik. Biomedical Engineering|December 22, 1998
[Equipment for modification of nuclear medicine lung diagnosis as triggered SPECT--presentation, phantom studies and clinical value]M Andreeff, J Kropp, B Beuthien-Baumann, et al.
Leukemia & Lymphoma|January 1, 1995
Growth-factor stimulation reveals two mechanisms of retinoblastoma gene inactivation in human myelogenous leukemia cellsW Zhang, H J Xu, S M Kornblau, et al.
Human Gene Therapy|June 28, 2001
Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenesS Takahashi, R F Rousseau, P Yotnda, et al.
Cancer Research|September 1, 1983
Flow cytometry in clinical cancer researchB Barlogie, M N Raber, J Schumann, et al.
Leukemia|February 1, 1989
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocolE Berman, Z A Arlin, J Gaynor, et al.
Seminars in Oncology|February 1, 1989
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer CenterE Berman, V Raymond, T Gee, et al.
Journal of Hematotherapy|January 1, 1993
Genetic therapy of human neoplastic diseaseA B Deisseroth, E G Hanania, S Fu, et al.
Pageof 32